Also written by Jacob Passy:
The Depressing Reason Why Executives Receive Such Massive salaries
x hide permanently

Cigna’s Express Scripts Deal Could Lead to Higher Prices for Consumers

MarketWatch

In an open letter released Tuesday, Carl Icahn has taken issue with Cigna’s planned acquisition of pharmacy-benefits manager Express Scripts Holding Company. The billionaire activist shareholder called the price tag “ridiculous.” But critics say consumers could also end up overpaying if the deal goes through. Cigna CI, +0.97% announced in March that it planned to purchase Express Scripts ESRX, +1.69% for $54 billion in cash and stock. The deal has a total transaction value of $67 billion...

Mentions: CEO Carl Icahn Amazon